TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple ...

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 Consortium of …

Fast Five Quiz: Multiple Sclerosis and Depression

Depression is among the most common comorbidities of multiple sclerosis (MS), leading to psychological quality-of-life issues that can further exacerbate a patient’s functional capacity. The significant burden of depression in patients with MS is typically …

Roche's Multiple Sclerosis Drug Shows Low Disease Activity Over Two Years

Roche Holdings AG RHHBY on Friday announced new 96-week data for fenebrutinib demonstrating that patients with relapsing multiple sclerosis (RMS) maintained no disability progression and low disease activity levels for up to two years. The latest results …

Roche shares positive 96-week results for multiple sclerosis candidate fenebrutinib

Roche has shared positive new 96-week data for its investigational fenebrutinib in patients with relapsing forms of multiple sclerosis (MS). Results from the phase 2 FENopta open-label extension (OLE) study, presented at this year’s Consortium of Multiple …

World MS Day: Expert explains why Ireland has such high rates of Multiple Sclerosis

09:23 ET, 30 May 2025 Multiple sclerosis (MS) is a chronic, often unpredictable condition that affects the brain and spinal cord. It occurs when the immune system mistakenly attacks the protective coating around nerves, leading to problems with movement, …

What it feels like: Living with multiple sclerosis through kindness and empowerment

Her unique symptoms aren’t always present with people in MS, but for her, it can lead to significant discomfort that only a fork by her bedside can solve. Fighting against self-stigma and making lemonade out of lemons Gaby spent a lot of the early days …

Roche’s 96-week data for multiple sclerosis drug; ZymeWorks claims $20M milestone

Diagnosed with multiple sclerosis: Managing treatments and building a support system

“I thought that’s kind of a relief, but I still don’t know what’s happening to me,” she said. During the holiday season of 2019, Karen was hit with urgent and critical symptoms that led her back to her family physician, where she requested an investigation …

ZHO launches MS support initiative on World Multiple Sclerosis Day

Abu Dhabi: The Zayed Higher Organization for People of Determination has unveiled a pioneering initiative to support employees living with Multiple Sclerosis (MS), a condition officially recognized as a physical disability. The initiative, coinciding with …

World Multiple Sclerosis Day 2025: Symptoms And Causes You Must Be Aware Of

Last Updated:May 30, 2025, 07:20 IST World Multiple Sclerosis Day 2025: MS affects millions globally and remains a chronic, often disabling disease surrounded by stigma and misunderstanding. World Multiple Sclerosis Day 2025: The day encourages people to …